Frings Andreas, Steinberg Johannes, Druchkiv Vasyl, Linke Stephan J, Katz Toam
Department of Ophthalmology, University Medical Centre Hamburg-Eppendorf (UKE), Martinistraße 52, 20246, Hamburg, Germany.
Graefes Arch Clin Exp Ophthalmol. 2016 Jul;254(7):1399-404. doi: 10.1007/s00417-016-3308-z. Epub 2016 Mar 3.
Previous studies have suggested that, to improve refractive predictability in hyperopic LASIK treatments, preoperative cycloplegic or manifest refraction, or a combination of both, could be used in the laser nomogram. We set out to investigate (1) the prevalence of a high difference between manifest and cycloplegic spherical equivalent in hyperopic eyes preoperatively, and (2) the related predictability of postoperative keratometry.
Retrospective cross-sectional data analysis of consecutive treated 186 eyes from 186 consecutive hyperopic patients (mean age 42 [±12] years) were analyzed. Excimer ablation for all eyes was performed using a mechanical microkeratome (SBK, Moria, France) and an Allegretto excimer laser platform. Two groups were defined according to the difference between manifest and cycloplegic spherical equivalent which was defined as ≥1.00 diopter (D); the data was analyzed according to refractive outcome in terms of refractive predictability, efficacy, and safety.
In 24 eyes (13 %), a preoperative difference of ≥1.00D between manifest spherical equivalent and cycloplegic spherical equivalent (= MCD) occurred. With increasing preoperative MCD, the postoperative achieved spherical equivalent showed hyperopic regression after 3 months. There was no statistically significant effect of age (accommodation) or optical zone size on the achieved spherical equivalent.
A difference of ≥1.00D occurs in about 13 % of hyperopia cases. We suggest that hyperopic correction should be based on the manifest spherical equivalent in eyes with preoperative MCD <1.00D. If the preoperative MCD is ≥1.00D, treatment may produce manifest undercorrection, and therefore we advise that the patient should be warrned about lower predictability, and suggest basing conclusions on the arithmetic mean calculated from the preoperative manifest and cycloplegic spheres.
以往研究表明,为提高远视性准分子激光原位角膜磨镶术(LASIK)治疗的屈光预测性,可在激光验光程序中使用术前睫状肌麻痹验光或显验光,或两者结合。我们旨在研究(1)远视眼术前显验光和睫状肌麻痹验光的等效球镜度数差异较大的发生率,以及(2)术后角膜曲率测量的相关预测性。
对连续186例远视患者(平均年龄42[±12]岁)的186只连续治疗眼进行回顾性横断面数据分析。所有眼睛均使用机械微型角膜刀(法国Moria公司的SBK)和Allegretto准分子激光平台进行准分子消融。根据显验光和睫状肌麻痹验光的等效球镜度数差异定义为≥1.00屈光度(D)分为两组;根据屈光预测性、有效性和安全性方面的屈光结果对数据进行分析。
24只眼(13%)术前显验光等效球镜度数与睫状肌麻痹验光等效球镜度数之间的差异≥1.00D(=MCD)。随着术前MCD的增加,术后3个月时等效球镜度数出现远视性回退。年龄(调节)或光学区大小对术后等效球镜度数无统计学显著影响。
约13%的远视病例存在≥1.00D的差异。我们建议,对于术前MCD<1.00D的眼睛,远视矫正应基于显验光等效球镜度数。如果术前MCD≥1.00D,治疗可能会导致明显的欠矫,因此我们建议应告知患者预测性较低,并建议根据术前显验光和睫状肌麻痹验光球镜度数计算的算术平均值得出结论。